Amneal Pharmaceuticals Quote - AMRX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

8.07

Bid

8.07

Offer

8.26

Volume

1,276,844

7.69 Day's Range 8.18

5.01 52 Week Range 9.475

Market Cap

2.5B

Previous Close

7.75

Open

7.74

Last Trade

8.0706

Last Trade Time

Financial Volume

US$ 10,298,737

VWAP

8.0658

Average Volume (3m)

1,034,257

Shares Outstanding

309,844,430

Dividend Yield

PE Ratio

-21.65

Earnings Per Share (EPS)

-0.27

Revenue

2.41B

Net Profit

-83.99M

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.amneal.com

Headquarters

Wilmington, Delaware, USA

Founded

Amneal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AMRX. The last closing price for Amneal Pharmaceuticals was US$7.75. Over the last year, Amneal Pharmaceuticals shares have traded in a share price range of US$ 5.01 to US$ 9.475.

Amneal Pharmaceuticals currently has 309,844,430 shares in issue. The market capitalisation of Amneal Pharmaceuticals is US$2.40 billion. Amneal Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.65.

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist

Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in developing GLP-1 injectables Amneal...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	8.07	8.33	7.68	803147	7.93993838	CS
4	-0.2	-2.41837968561	8.27	8.9	7.68	1067201	8.35347155	CS
12	-0.45	-5.28169014085	8.52	9.475	7.52	1034257	8.51937607	CS
26	1.22	17.8102189781	6.85	9.475	6.29	1252219	7.91645198	CS
52	2.19	37.2448979592	5.88	9.475	5.01	1372535	6.8894188	CS
156	2.19	37.2448979592	5.88	9.475	5.01	1372535	6.8894188	CS
260	2.19	37.2448979592	5.88	9.475	5.01	1372535	6.8894188	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUKKNukkleus Inc	US$ 11.655 (738.49%)	174.4M
PRTGPortage Biotech Inc	US$ 8.8678 (172.86%)	36.61M
OPTXSyntec Optics Holdings Inc	US$ 3.55 (99.44%)	93.16M
PTPIPetros Pharmaceuticals Inc	US$ 0.4976 (86.37%)	63.49M
LUXHLuxUrban Hotels Inc	US$ 0.849899 (59.67%)	29.52M
VCNXVaccinex Inc	US$ 1.41 (-61.37%)	758.95k
TNYATenaya Therapeutics Inc	US$ 1.395 (-51.56%)	42.45M
ORKTOrangeKloud Technology Inc	US$ 2.14 (-41.85%)	2.29M
RVPHReviva Pharmaceuticals Holdings Inc	US$ 1.395 (-39.35%)	18.16M
DBGIDigital Brands Group Inc	US$ 2.46 (-37.88%)	805.23k
RIMEAlgorhythm Holdings Inc	US$ 0.0877 (8.27%)	1.13B
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.335 (-36.79%)	1B
GOEVCanoo Inc	US$ 0.118 (7.08%)	382.65M
NVDANVIDIA Corporation	US$ 130.39 (-1.22%)	251.71M
XTIAXTI Aerospace Inc	US$ 0.0442 (8.33%)	221.41M